Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Biosante Pharmaceuticals Inc

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biosante Pharmaceuticals Inc since year 2005 are given in the first table. The second table lists detailed insider transactions reported by Biosante Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is BPAX. The reporting company's CIK number is 1023024. The total value of stock buying during this period is $954,173. The total value of stock sales is $495,727. The total value of stock exercises is $351,469.

Figure 1. Monthly insider transaction values at Biosante Pharmaceuticals Inc (BPAX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $332,465

    $33,246

    $3,324

    $332

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Biosante Pharmaceuticals Inc (BPAX) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $6.83

    $5.12

    $3.41

    $1.71



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biosante Pharmaceuticals Inc (BPAX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-05 15,000 53,827 0 0 0 0
2008-01 65,000 240,951 0 0 0 0
2007-12 88,000 332,465 0 0 0 0
2007-05 0 0 7,500 50,883 0 0
2006-12 15,000 40,369 0 0 0 0
2006-11 100,000 150,000 0 0 0 0
2006-09 50,000 80,000 0 0 0 0
2006-07 29,600 56,561 0 0 0 0
2006-03 0 0 0 0 152,813 351,469
2005-04 0 0 115,277 444,844 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Biosante Pharmaceuticals Inc (BPAX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-05-12 Mangano Ross J (Director) Purchase 15,000 3.59 53,827
2008-01-08 Kjaer Peter (Director) Purchase 7,700 3.66 28,220
2008-01-07 Kjaer Peter (Director) Purchase 7,300 3.59 26,226
2008-01-04 Mangano Ross J (Director) Purchase 50,000 3.73 186,505
2007-12-20 Mangano Ross J (Director) Purchase 25,000 3.98 99,500
2007-12-19 Mangano Ross J (Director) Purchase 50,000 3.69 184,700
2007-12-14 Donenberg Philip B (CFO, Treasurer and Secretary) Purchase 2,000 3.76 7,510
2007-12-14 Simes Stephen M (Vice Chair, President & CEO) Purchase 10,000 3.70 37,000
2007-05-07 Holubow Fred (Director) Sale 2,000 6.92 13,850
2007-05-04 Holubow Fred (Director) Sale 5,500 6.73 37,033
2006-12-26 Mangano Ross J (Director) Purchase 15,000 2.69 40,369
2006-11-16 Mangano Ross J (Director) Purchase 100,000 1.50 150,000
2006-09-28 Morgenstern Victor A (Director) Purchase 50,000 1.60 80,000
2006-07-20 Donenberg Philip B (CFO, Treasurer and Secretary) Purchase 1,000 1.94 1,945
2006-07-19 Mangano Ross J (Director) Purchase 14,800 1.90 28,120
2006-07-14 Mangano Ross J (Director) Purchase 13,800 1.92 26,496
2006-03-27 Donenberg Philip B (CFO, Treasurer and Secretary) Option Exercise 52,188 2.30 120,032
2006-03-27 Simes Stephen M (Vice Chairman, President & CEO) Option Exercise 100,625 2.30 231,437
2005-04-21 Bell Steven J (Pre-Clinical Dev) Sale 4,100 4.01 16,514
2005-04-19 Lehman Leah M (Vice President, Prod) Sale 80,377 3.78 304,146
2005-04-14 Lehman Leah M (Vice President, Prod) Sale 29,400 4.04 118,629

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biosante Pharmaceuticals Inc (symbol BPAX, CIK number 1023024) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.